Company Cami Pharm Srl with Fiscal Code 19113477
recorded a turnover of 2024 of
416.481,
with a net profit of
10.305
and having an average number of employees of
4.
The company operates in the field of Comerţ cu amănuntul al produselor farmaceutice having the NACE code 4773.
Sales - Ron
Sales, Profit, Employees, Total Income, Financial Results -
Cami Pharm Srl
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Sales - EUR
196.260
219.516
224.653
247.049
259.392
312.255
328.819
355.462
372.522
416.481
Total Income - EUR
196.348
219.647
224.828
247.348
259.731
317.676
331.546
357.095
375.582
430.522
Total Expenses - EUR
195.500
215.944
223.395
241.422
255.068
306.456
316.396
345.730
376.837
418.575
Gross Profit/Loss - EUR
848
3.704
1.433
5.926
4.663
11.220
15.150
11.365
-1.254
11.947
Net Profit/Loss - EUR
848
2.928
533
4.584
3.927
9.777
13.147
9.453
-1.439
10.305
Employees
3
3
3
3
3
4
4
4
4
4
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
In the last year of activity, the sales increased by 12.4%, from 372.522 euro in the year 2023, to 416.481 euro in 2024.
The Net Profit increased by 10.305 euro, from 0 euro in 2023, to 10.305 in the last year.
Check the financial reports for the company - Cami Pharm Srl
Financial Rating - CAMI PHARM SRL
See the company's note based on the submitted financial data, relative to the industry of which it is a part.
Financial Rating
Payment Limits - Cami Pharm Srl
See the company's payment capacity for situations in which you conclude contracts with payment terms.
Check Payment Limits
Prob. of insolvency - Cami Pharm Srl
It determines the risk of insolvency based on the submitted accounting balance.
Insolvency Probability
Financial Reports - Cami Pharm Srl
Check all the financial reports of the company and know the risks in collaboration with it.
Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
Debts, Equity, Inventories, Receivables, Accounts, Assets -
Cami Pharm Srl - CUI 19113477
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Fixed Assets
2.509
2.632
2.220
4.748
6.511
10.350
8.406
20.949
17.276
1.778
Current Assets
65.517
70.154
71.187
73.028
78.467
93.687
108.522
85.865
94.345
110.625
Inventories
26.169
28.348
26.470
25.636
29.096
28.053
32.091
30.141
38.611
33.211
Receivables
26.728
11.761
24.484
43.620
38.130
44.556
44.460
44.479
45.183
47.341
Cash
12.620
30.045
20.233
3.772
11.242
21.078
31.971
11.245
10.551
30.073
Shareholders Funds
26.217
28.878
26.043
30.149
33.492
42.634
54.836
27.861
25.804
36.853
Social Capital
45
45
9.851
9.670
9.483
9.303
9.097
9.125
9.097
9.046
Debts
41.809
43.908
47.601
47.964
51.738
61.711
62.092
69.002
77.679
73.527
Income in Advance
0
0
0
0
0
0
0
10.203
8.138
2.023
Exchange rate - RON
4.9743
4.9465
4.9315
4.9468
4.8371
4.7454
4.6535
4.5681
4.4908
4.445
Main CAEN
"4773 - 4773"
CAEN Financial Year
4773
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
110.625 euro in 2024 which includes Inventories of
33.211 euro, Receivables of
47.341 euro and cash availability of
30.073 euro.
The company's Equity was valued at
36.853 euro, while total Liabilities amounted to
73.527 euro.
Equity increased by 11.193 euro, from 25.804 euro in 2023, to 36.853 in 2024.
The Debt Ratio was 65.4% in the year 2024.
Similar services useful for checking companies and business development.
SellNet
Get the contact details for any company and get in touch with it.
Sectoral Studies
Knows the market and develops its own development strategies according to sectorial data.
Databases
Export in excel files the data of the companies selected according to the desired criteria.
Import - Export
Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Cami Pharm Srl